Skip to main content
Year archive

Xvivo Perfusion — 2023 filings

All 28 regulatory filings released by Xvivo Perfusion (XVIVO) in 2023, sourced directly from the official regulator.

28 Filings
2023 Period
2023 filings (28)
Filing Released Lang
XVIVO meddelar en nedskrivning relaterad till PrimECC om 17 MSEK vilket ej påverkar kassaflöde eller EBITDA
Earnings Release Q4 2023
2023-12-14 Swedish
XVIVO announces a write-down related to PrimECC of SEK 17 million not affecting cashflow or EBITDA
Legal Proceedings Report
2023-12-14 English
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-10-24 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-10-24 English
Increased number of shares and votes in XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-09-29 English
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
Share Issue/Capital Change
2023-09-29 Swedish
XVIVO has carried out a directed share issue of 1,600,000 shares at a subscription price of SEK 275 per share, raising gross proceeds of SEK 440 million
Share Issue/Capital Change
2023-09-13 English
XVIVO har genomfört en riktad nyemission av 1 600 000 aktier till en teckningskurs om 275 kronor per aktie och tillförs en bruttolikvid om 440 miljoner kronor
Share Issue/Capital Change
2023-09-13 Swedish
XVIVO avser att genomföra en riktad nyemission av aktier
Capital/Financing Update
2023-09-13 Swedish
XVIVO intends to carry out a directed share issue
Capital/Financing Update
2023-09-13 English
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-07-13 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-07-13 English
XVIVO has decided to close the PrimECC® study for further patient inclusions – strategic opportunities will be evaluated
Regulatory Filings
2023-07-12 English
XVIVO har beslutat att avsluta ytterligare patientinkludering i studien av PrimECC® – strategiska möjligheter skall utvärderas
Report Publication Announcement
2023-07-12 Swedish
XVIVO conducts a commercial integration of STAR Teams in the US - strengthening the service offering
Regulatory Filings
2023-06-21 English
XVIVO stärker tjänsteerbjudandet i USA genom en kommersiell integration av STAR Teams
M&A Activity
2023-06-21 Swedish
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-05-31 Swedish
Increased number of shares and votes in XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-05-31 English
XVIVO Perfusion AB (publ) genomför nyemission av aktier genom kvittning av fordringar
Capital/Financing Update
2023-05-11 Swedish
XVIVO Perfusion AB (publ) carries out new issue of shares through set off of claims
Share Issue/Capital Change
2023-05-11 English
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2023-04-25 Swedish
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
AGM Information
2023-04-25 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-04-24 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-04-24 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-03 Swedish
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-03 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q4 2022
2023-01-26 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-01-26 English